An activating mutation in AKT1 (E17K), which results in the growth factor-independent membrane translocation of Akt and increased phosphorylation levels [37], was identified in various types of cancers, including melanoma and breast, esophageal, colorectal, endometrial, ovarian, and nonsmall cell lung cancers [38]. Here, AKT1 is linked to lung cancer.